Healthcare provider profile · identity verified

James L Williams, MD

Allopathic & Osteopathic Physicians|Family Medicine · TRENTON, TN · NPI 1912918491

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James L Williams, MD received $597.18 in general payments during 2025 across 12 reported records.

ABIOMED accounted for 61.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Gemtesa.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Brilinta by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 259 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Symbicort by this doctor in 2024.

Sumitomo Pharma America, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported GEMTESA as an associated drug or biological on 61692 records involving 22152 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Gemtesa by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$597.18

12 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABIOMED	Unresolved — no canonical attribution shown	$367.43	61.5%	6	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$136.22	22.8%	2	2025
Sumitomo Pharma America, Inc.	Unresolved — no canonical attribution shown	$42.51	7.1%	2	2025
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$27.15	4.5%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$23.87	4.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$597.18	12

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$125.00	1	2025
Source payment records 2025-02-26 · AstraZeneca Pharmaceuticals LP · $125.00 · Open Payments source
GEMTESA Normalized: gemtesa	Drug	Sumitomo Pharma America, Inc.	$42.51	2	2025
Source payment records 2025-06-04 · Sumitomo Pharma America, Inc. · $21.24 · Open Payments source 2025-07-23 · Sumitomo Pharma America, Inc. · $21.27 · Open Payments source
WATCHMAN Access System Normalized: watchman access system	Device	Boston Scientific Corporation	$27.15	1	2025
Source payment records 2025-11-10 · Boston Scientific Corporation · $27.15 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$23.87	1	2025
Source payment records 2025-04-09 · Exact Sciences Corporation · $23.87 · Open Payments source
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$11.22	1	2025
Source payment records 2025-12-03 · AstraZeneca Pharmaceuticals LP · $11.22 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	259	exact normalized	Medicare Part D
GEMTESA gemtesa	2025	Gemtesa	2024	43 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	BRILINTA open payments reported associated product	CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430	Brilinta · 2024 Exact normalized brand match · 1 Part D row	91	suppressed by CMS
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	259	33
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	30	suppressed by CMS
Sumitomo Pharma America, Inc. Exact reporting entity; no affiliate inference	2025	GEMTESA open payments reported associated product	CMS Open Payments — General Payments 61692 supporting records · 22152 recipient NPIs · example record 1176593503	Gemtesa · 2024 Exact normalized brand match · 1 Part D row	43	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	1145	144
Atorvastatin Calcium	Atorvastatin Calcium	1094	217
Furosemide	Furosemide	1066	166
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	962	136
Levothyroxine Sodium	Levothyroxine Sodium	837	92
Pantoprazole Sodium	Pantoprazole Sodium	752	153
Lisinopril	Lisinopril	751	150
Metformin Hcl	Metformin Hcl	695	131
Metoprolol Tartrate	Metoprolol Tartrate	693	95
Gabapentin	Gabapentin	690	102
Amlodipine Besylate	Amlodipine Besylate	576	123
Omeprazole	Omeprazole	560	116
Losartan Potassium	Losartan Potassium	550	138
Eliquis	Apixaban	540	53
Clopidogrel	Clopidogrel Bisulfate	453	86
Tamsulosin Hcl	Tamsulosin Hcl	450	99
Simvastatin	Simvastatin	419	83
Metoprolol Succinate	Metoprolol Succinate	399	61
Meloxicam	Meloxicam	377	83
Jardiance	Empagliflozin	373	38
Famotidine	Famotidine	368	96
Fluoxetine Hcl	Fluoxetine Hcl	356	75
Hydrochlorothiazide	Hydrochlorothiazide	343	73
Allopurinol	Allopurinol	333	61
Rosuvastatin Calcium	Rosuvastatin Calcium	282	56
Potassium Chloride	Potassium Chloride	276	59
Glimepiride	Glimepiride	273	59
Farxiga	Dapagliflozin Propanediol	259	33
Mirtazapine	Mirtazapine	257	51
Ozempic	Semaglutide	252	35
Tramadol Hcl	Tramadol Hcl	245	45
Albuterol Sulfate Hfa	Albuterol Sulfate	232	54
Carvedilol	Carvedilol	229	57
Zolpidem Tartrate	Zolpidem Tartrate	226	30
Sertraline Hcl	Sertraline Hcl	223	37
Trazodone Hcl	Trazodone Hcl	206	32
Tizanidine Hcl	Tizanidine Hcl	192	48
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	189	38
Isosorbide Mononitrate Er	Isosorbide Mononitrate	185	36
Montelukast Sodium	Montelukast Sodium	184	38
Diclofenac Sodium	Diclofenac Sodium	183	46
Ropinirole Hcl	Ropinirole Hcl	183	34
Buspirone Hcl	Buspirone Hcl	182	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	178	31
Pregabalin	Pregabalin	177	26
Pravastatin Sodium	Pravastatin Sodium	166	31
Topiramate	Topiramate	165	31
Dicyclomine Hcl	Dicyclomine Hcl	164	41
Hydralazine Hcl	Hydralazine Hcl	158	28
Myrbetriq	Mirabegron	158	21
Lorazepam	Lorazepam	153	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	144	30
Cephalexin	Cephalexin	143	108
Linzess	Linaclotide	142	27
Promethazine Hcl	Promethazine Hcl	142	45
Clonazepam	Clonazepam	139	20
Duloxetine Hcl	Duloxetine Hcl	139	30
Ibuprofen	Ibuprofen	138	25
Fluticasone Propionate	Fluticasone Propionate	135	34
Shingrix	Varicella-Zoster Ge/As01b/Pf	134	102
Hydroxyzine Hcl	Hydroxyzine Hcl	130	35
Clonidine Hcl	Clonidine Hcl	126	29
Citalopram Hbr	Citalopram Hydrobromide	124	30
Prednisone	Prednisone	124	56
Baclofen	Baclofen	123	34
Amitriptyline Hcl	Amitriptyline Hcl	121	22
Spironolactone	Spironolactone	120	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	119	25
Entresto	Sacubitril/Valsartan	118	14
Escitalopram Oxalate	Escitalopram Oxalate	118	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	118	23
Donepezil Hcl	Donepezil Hcl	113	17
Triamcinolone Acetonide	Triamcinolone Acetonide	108	48
Methocarbamol	Methocarbamol	107	22
Nuedexta	Dextromethorphan Hbr/Quinidine	106	suppressed
Dutasteride	Dutasteride	101	19
Nystatin	Nystatin	101	45
Sucralfate	Sucralfate	101	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	100	15
Doxepin Hcl	Doxepin Hcl	99	17
Metformin Hcl Er	Metformin Hcl	97	22
Memantine Hcl	Memantine Hcl	96	16
Celecoxib	Celecoxib	94	22
Brilinta	Ticagrelor	91	suppressed
Mounjaro	Tirzepatide	88	11
Diazepam	Diazepam	85	11
Primidone	Primidone	84	12
Esomeprazole Magnesium	Esomeprazole Magnesium	83	14
Fluconazole	Fluconazole	82	35
Valsartan	Valsartan	81	suppressed
Benazepril Hcl	Benazepril Hcl	80	11
Carbidopa-Levodopa	Carbidopa/Levodopa	80	12
Atenolol	Atenolol	78	18
Quetiapine Fumarate	Quetiapine Fumarate	78	15
Metoclopramide Hcl	Metoclopramide Hcl	77	18
Paroxetine Hcl	Paroxetine Hcl	77	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	73	73
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	73	11
Tresiba Flextouch U-100	Insulin Degludec	73	12
Methylprednisolone	Methylprednisolone	72	62
Klor-Con 10	Potassium Chloride	71	suppressed
Amiodarone Hcl	Amiodarone Hcl	68	11
Warfarin Sodium	Warfarin Sodium	68	13
Nifedipine Er	Nifedipine	67	13
Lactulose	Lactulose	66	suppressed
Temazepam	Temazepam	66	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	62	38
Tresiba Flextouch U-200	Insulin Degludec	62	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	16
Bupropion Hcl Sr	Bupropion Hcl	58	14
Lovastatin	Lovastatin	57	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	31
Levetiracetam	Levetiracetam	56	12
Glipizide	Glipizide	55	suppressed
Lamotrigine	Lamotrigine	55	suppressed
Meclizine Hcl	Meclizine Hcl	55	18
Sotalol	Sotalol Hcl	54	suppressed
Sulfasalazine	Sulfasalazine	53	suppressed
Estradiol	Estradiol	52	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	52	suppressed
Vraylar	Cariprazine Hcl	51	11
Risperidone	Risperidone	50	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	12
Doxazosin Mesylate	Doxazosin Mesylate	49	12
Rivastigmine	Rivastigmine Tartrate	49	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	13
Bupropion Xl	Bupropion Hcl	47	suppressed
Colchicine	Colchicine	47	suppressed
Propranolol Hcl	Propranolol Hcl	47	11
Terazosin Hcl	Terazosin Hcl	47	suppressed
Carbamazepine	Carbamazepine	46	suppressed
Levemir	Insulin Detemir	46	suppressed
Divalproex Sodium	Divalproex Sodium	45	suppressed
Januvia	Sitagliptin Phosphate	45	suppressed
Mupirocin	Mupirocin	45	30
Ondansetron Hcl	Ondansetron Hcl	45	23
Olmesartan Medoxomil	Olmesartan Medoxomil	44	12
Venlafaxine Hcl Er	Venlafaxine Hcl	44	11
Gemtesa	Vibegron	43	suppressed
Levemir Flexpen	Insulin Detemir	43	suppressed
Xarelto	Rivaroxaban	43	suppressed
Midodrine Hcl	Midodrine Hcl	42	suppressed
Acyclovir	Acyclovir	41	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	41	suppressed
Ranolazine Er	Ranolazine	41	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	41	suppressed
Metolazone	Metolazone	40	14
Synthroid	Levothyroxine Sodium	40	suppressed
Fenofibrate	Fenofibrate	39	suppressed
Methotrexate	Methotrexate Sodium	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Indomethacin	Indomethacin	38	suppressed
Nebivolol Hcl	Nebivolol Hcl	38	suppressed
Rexulti	Brexpiprazole	38	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	30
Nitroglycerin	Nitroglycerin	36	16
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Bumetanide	Bumetanide	33	suppressed
Ketoconazole	Ketoconazole	32	suppressed
Rybelsus	Semaglutide	32	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	32	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	31
Lantus	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Torsemide	Torsemide	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Amoxicillin	Amoxicillin	26	14
Bupropion Hcl	Bupropion Hcl	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Oxcarbazepine	Oxcarbazepine	26	suppressed
Cilostazol	Cilostazol	25	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	25	suppressed
Nuplazid	Pimavanserin Tartrate	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Humalog	Insulin Lispro	24	suppressed
Rizatriptan	Rizatriptan Benzoate	24	suppressed
Veozah	Fezolinetant	24	suppressed
Carisoprodol	Carisoprodol	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	14
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Irbesartan	Irbesartan	22	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	11
Cyproheptadine Hcl	Cyproheptadine Hcl	21	suppressed
Lurasidone Hcl	Lurasidone Hcl	21	suppressed
Metronidazole	Metronidazole	21	13
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Calcitriol	Calcitriol	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	13
Naproxen	Naproxen	20	suppressed
Ramipril	Ramipril	20	suppressed
Veltassa	Patiromer Calcium Sorbitex	20	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Budesonide	Budesonide	18	suppressed
Dilt-Xr	Diltiazem Hcl	18	suppressed
Theophylline Er	Theophylline Anhydrous	18	suppressed
Tiotropium Bromide	Tiotropium Bromide	18	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Digoxin	Digoxin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Prasugrel Hcl	Prasugrel Hcl	17	suppressed
Zonisamide	Zonisamide	17	suppressed
Finasteride	Finasteride	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Methimazole	Methimazole	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	11
Enulose	Lactulose	15	suppressed
Formoterol Fumarate	Formoterol Fumarate	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Cefepime Hcl	Cefepime Hcl	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Quviviq	Daridorexant Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Etodolac	Etodolac	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Glyburide	Glyburide	13	suppressed
Insulin Aspart	Insulin Aspart	13	suppressed
Qulipta	Atogepant	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Entacapone	Entacapone	12	suppressed
Isosorbide Dinit-Hydralazine	Isosorbide Dinit/Hydralazine	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nystop	Nystatin	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Procrit	Epoetin Alfa	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Kerendia	Finerenone	11	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Xeljanz Xr	Tofacitinib Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$597.18 · 12 records	ABIOMED	BREZTRI, Cologuard Collection Kit, FARXIGA, GEMTESA, WATCHMAN Access System	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error